Cargando…

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

Myeloid-derived suppressor cells (MDSCs) enhance tumor progression by suppressing tumor-specific T cell responses, stimulating tumor angiogenesis, or promoting tumor cell metastasis. However, the biology of MDSCs have not been fully investigated. In the current study, we investigated the role of MDS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuroda, Hiromasa, Mabuchi, Seiji, Yokoi, Eriko, Komura, Naoko, Kozasa, Katsumi, Matsumoto, Yuri, Kawano, Mahiru, Takahashi, Ryoko, Sasano, Tomoyuki, Shimura, Kotaro, Kodama, Michiko, Hashimoto, Kae, Sawada, Kenjiro, Morii, Eiichi, Kimura, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284736/ https://www.ncbi.nlm.nih.gov/pubmed/30555631 http://dx.doi.org/10.18632/oncotarget.26347

Ejemplares similares

Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental models
por: Kozasa, Katsumi, et al.
Publicado: (2019)

Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer
por: Shimura, Kotaro, et al.
Publicado: (2021)

Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies
por: Mabuchi, Seiji, et al.
Publicado: (2020)

Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review
por: Kozasa, Katsumi, et al.
Publicado: (2017)

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary
por: Takahashi, Ryoko, et al.
Publicado: (2016)

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
por: Kawano, Mahiru, et al.
Publicado: (2015)

Prognostic significance of the pretreatment prognostic nutritional index in patients with epithelial ovarian cancer
por: Komura, Naoko, et al.
Publicado: (2019)

Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma
por: Yokoi, Eriko, et al.
Publicado: (2017)

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy
por: Yoshimura, Akihiko, et al.
Publicado: (2018)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice
por: Shimura, Kotaro, et al.
Publicado: (2013)

Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors
por: Matsuo, Koji, et al.
Publicado: (2015)

Premetastatic niche and tumor-related leukocytosis: a close relationship that cannot be ignored in uterine cancer patients
por: Mabuchi, Seiji, et al.
Publicado: (2018)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy
por: Mabuchi, Seiji, et al.
Publicado: (2022)

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination
por: Nakatsuka, Erika, et al.
Publicado: (2017)

Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive Radiotherapy
por: Kuruma, Airi, et al.
Publicado: (2022)

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types
por: Kobayashi, Masaki, et al.
Publicado: (2018)

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells
por: Yoshimura, Akihiko, et al.
Publicado: (2018)

Safety and efficacy of Ninjin’yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial
por: Yagi, Taro, et al.
Publicado: (2022)

Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Two cases of giant peritoneal inclusion cysts requiring treatment after total laparoscopic hysterectomy
por: Kozasa, Katsumi, et al.
Publicado: (2020)

Comparison of the Survival Outcomes of Minimally Invasive Surgery with Open Surgery in Patients with Uterine-Confined and Node-Negative Cervical Cancer: A Population-Based Study
por: Mabuchi, Seiji, et al.
Publicado: (2023)

Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer
por: Isobe, Aki, et al.
Publicado: (2015)

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma
por: Kinose, Yasuto, et al.
Publicado: (2015)

Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters
por: Isohashi, Fumiaki, et al.
Publicado: (2015)

Efferocytosis and autoimmune disease
por: Kawano, Mahiru, et al.
Publicado: (2018)

Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)
por: Oride, Tadashi, et al.
Publicado: (2023)

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression
por: Nakamura, Koji, et al.
Publicado: (2019)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
por: Miyamoto, Mayuko, et al.
Publicado: (2020)

Resection of a colloid adenocarcinoma of the lung: A case report
por: Kogita, Yuya, et al.
Publicado: (2023)

A case of sarcomatoid malignant peritoneal mesothelioma diagnosed by laparoscopy
por: Kobayashi, Mariya, et al.
Publicado: (2020)

Laparoscopic spacer placement for bulky lymph node metastasis of cervical cancer: A case report
por: Kuruma, Airi, et al.
Publicado: (2022)

Significance of the Surgical Treatment with Lymph Node Dissection for Neuroendocrine Tumors of Thymus
por: Ose, Naoko, et al.
Publicado: (2023)

Soft X-ray Laser Microscopy of Lipid Rafts towards GPCR-Based Drug Discovery Using Time-Resolved FRET Spectroscopy
por: Baba, Motoyoshi, et al.
Publicado: (2011)

Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance
por: Chinen, Takatoshi, et al.
Publicado: (2011)

A single institution’s experience with minimally invasive surgery for ovarian cancer, and a systematic meta-analysis of the literature
por: Kamei, Yuji, et al.
Publicado: (2023)

Three-dimensional Imaging of Abducens Palsy by Neurovascular Compression
por: Sugimoto, Azusa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j82p0m9dil0m2se79l50qjrl9o